June 15, 2023
by Illia Petrov
Biopharma insight
Life sciences research has experienced significant shifts in its operational paradigms in recent years, driven largely by the advent and …
May 30, 2022
by Andrii Buvailo
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …
March 15, 2018
by Andrii Buvailo
Biopharma insight
(Last updated: 15.03.2018) The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate …
May 19, 2019
by Andrii Buvailo
Biopharma insight
Things like gene editing, stem cells, immunotherapies and new types of biologics are now mega-trends in the pharmaceutical industry, widely …
Nov. 18, 2019
by Tim Sandle
Biopharma insight
New legislation requiring pharmaceutical companies to implement 'serialization' is now coming into force. This means that no counterfeit product should …
Feb. 20, 2019
by Andrii Buvailo
Biopharma insight
In 1970-80s, the idea of virtual screening was regarded as a conceptual way to substitute costly and time-consuming experimental “screen-everything-you-have” …
Oct. 27, 2017
by Alfred Ajami
Biopharma insight
In a case of "back to the future", chemists at Scripps collaborating with instrument engineers at IKA have unveiled a …
Sept. 12, 2018
by Andrii Buvailo
Biopharma insight
Today Basel is crowded with some of the top business and research leaders representing a young and rapidly growing industry …
Feb. 19, 2020
by Irina Bilous
Biopharma insight
A transformative technology for gene editing - clustered regularly interspaced short palindromic repeats (CRISPR) -- has become ubiquitous, at least …
June 19, 2020
by Irina Bilous
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of molecules in the context of drug design is an emerging technological …
Dec. 6, 2017
by Alfred Ajami
Biopharma insight
The16th century alchemical and 19th century science fiction revival of a miniature human being in a test tube is undergoing …
April 15, 2021
by Aruna Rajan
Biopharma insight
2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome …